Starcef DS powder for syrup
Ingredients in every 5 ml
Each package contains
|ATC Level 1||J - Antiinfectives for systemic use|
|ATC Level 2||J01 - Antibacterials for Systemic Use|
|ATC Level 3||J01D - Other Beta-Lactam Antibacterials in ATC|
UP TO 18 YEARS
The usual daily dose for pediatric:
1.5-3 mg (0.075-0.15 ml of STARCEF dry syrup)/kg body weight given orally twice a day.
Dosage should be adjusted according to the condition of the patients.
For severe infections:
The dosage may be increased up to 6 mg (0.3 ml of STARCEF dry syrup)/kg body weight given twice a day.
In pediatrics with otitis media, it is recommended to treat with STARCEF dry syrup.
PATIENTS WITH IMPAIRED RENAL FUNCTION
Patients with impaired renal function need a dosage adjustment depending on the degree of renal impairment. Recommended dosage: 75% of the standard dosage (i.e. 300 mg a day) if creatinine clearance is between 21 and 60 ml/minute or for patients on renal hemodialysis and 50% of the standard dosage (i.e. 200 mg a day) if creatinine clearance is <20 ml/minute or for patients on continuous ambulatory dialysis.
Treatment of infections caused by susceptible microorganisms, i.e.:
a. Urinary infections without complication caused by Escherichia coli and Proteus mirabilis.
b. Otitis media caused by Haemophilus influenzae (ß-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are ß-lactamase positive) and Streptococcus pyogenes.
c. Pharyngitis and tonsillitis caused by Streptococcus pyogenes.
d. Acute bronchitis and acute exacerbation of chronic bronchitis, caused by Streptococcus pneumoniae and Haemophilus influenzae (ß-lactamase positive and negative strains).